F01 in the Treatment of Autoimmune Diseases
NCT06208280
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Autoimmune Diseases
Interventions
DRUG:
After preconditioning with Fludarabine and Cyclophosphamide, F01 will be evaluated.
Sponsor
RenJi Hospital
Collaborators
[object Object]